Dyne Therapeutics, Inc. (34)
Browse by Contract Category
Contracts
-
Severance agreement between Dyne Therapeutics, Inc. and Romesh Subramanian dated as of June 2, 2021
(Filed With SEC on August 5, 2021)
-
Lease by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended
(Filed With SEC on August 5, 2021)
-
Offer letter, dated as of December 17, 2020, by and between the registrant and Wildon Farwell
(Filed With SEC on March 4, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on January 19, 2021)
-
Form of Indemnification Agreement between the registrant and each of its executive officers and directors
(Filed With SEC on August 25, 2020)
-
License Agreement, dated as of April 27, 2020, by and between the registrant and the University of Mons
(Filed With SEC on August 25, 2020)
-
Lease by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended
(Filed With SEC on May 6, 2021)
-
Description of Securities Registered Under Section 12 of the Exchange Act
(Filed With SEC on March 4, 2021)
-
Lease, by and between the registrant and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020, as amended
(Filed With SEC on January 19, 2021)
-
Lease, by and between Dyne Therapeutics, Inc. and BP3-BOS1 1560 Trapelo Road LLC, dated as of December 4, 2020
(Filed With SEC on December 9, 2020)
-
2020 Employee Stock Purchase Plan
(Filed With SEC on September 10, 2020)
-
2020 Stock Incentive Plan
(Filed With SEC on September 10, 2020)
-
2018 Stock Incentive Plan, as amended
(Filed With SEC on September 10, 2020)
-
Specimen Stock Certificate evidencing the shares of common stock
(Filed With SEC on September 10, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on September 10, 2020)
-
Offer letter, dated as of November 8, 2019, by and between the registrant and Richard Scalzo
(Filed With SEC on August 25, 2020)
-
Executive Severance and Change in Control Benefits Plan
(Filed With SEC on August 25, 2020)
-
Offer letter, dated as of July 24, 2020, by and between the registrant and Susanna High
(Filed With SEC on August 25, 2020)
-
Amended and Restated Investors Rights Agreement dated as of August 7, 2020 by and among the registrant and the other parties thereto
(Filed With SEC on August 25, 2020)
-
2018 Stock Incentive Plan
(Filed With SEC on August 25, 2020)
-
2020 Employee Stock Purchase Plan
(Filed With SEC on August 25, 2020)
-
Form of Stock Option Agreement under 2018 Stock Incentive Plan
(Filed With SEC on August 25, 2020)
-
Form of Restricted Stock Agreement under 2018 Stock Incentive Plan
(Filed With SEC on August 25, 2020)
-
2020 Stock Incentive Plan
(Filed With SEC on August 25, 2020)
-
Form of Stock Option Agreement under 2020 Stock Incentive Plan
(Filed With SEC on August 25, 2020)
-
Form of Restricted Stock Agreement under 2020 Stock Incentive Plan
(Filed With SEC on August 25, 2020)
-
Form of Restricted Stock Unit Agreement under 2020 Stock Incentive Plan
(Filed With SEC on August 25, 2020)
-
Sublease Agreement, dated May 20, 2019, by and between Arrakis Therapeutics, Inc., as sublandlord, and the registrant, as subtenant
(Filed With SEC on August 25, 2020)
-
Offer letter, dated as of December 21, 2018, by and between the registrant and Jonathan McNeill
(Filed With SEC on August 25, 2020)
-
Loan and Security Agreement, dated as of February 20, 2020, by and between the registrant and Pacific Western Bank
(Filed With SEC on August 25, 2020)
-
Offer letter, dated as of September 19, 2019, by and between the registrant and Joshua Brumm
(Filed With SEC on August 25, 2020)
-
Offer letter, dated as of March 21, 2018, by and between the registrant and Romesh Subramanian
(Filed With SEC on August 25, 2020)
-
Employment side letter, dated as of November 29, 2018, by and between the registrant and Romesh Subramanian
(Filed With SEC on August 25, 2020)
-
Offer letter, dated as of December 12, 2019, by and between the registrant and Oxana Beskrovnaya
(Filed With SEC on August 25, 2020)
